Cognyte Software Ltd. (NASDAQ:CGNT - Get Free Report) was the recipient of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 475,900 shares, a growth of 44.6% from the March 31st total of 329,100 shares. Currently, 0.7% of the shares of the company are short sold. Based on an average daily volume of 375,200 shares, the short-interest ratio is presently 1.3 days.
Institutional Trading of Cognyte Software
A number of institutional investors and hedge funds have recently made changes to their positions in CGNT. Tower Research Capital LLC TRC bought a new stake in shares of Cognyte Software during the 4th quarter worth approximately $37,000. Quantbot Technologies LP bought a new position in Cognyte Software in the 3rd quarter valued at approximately $57,000. Russell Investments Group Ltd. lifted its stake in Cognyte Software by 8,624.3% in the 4th quarter. Russell Investments Group Ltd. now owns 20,066 shares of the medical device company's stock valued at $129,000 after purchasing an additional 19,836 shares during the last quarter. Mackenzie Financial Corp lifted its stake in Cognyte Software by 56.1% in the 4th quarter. Mackenzie Financial Corp now owns 21,986 shares of the medical device company's stock valued at $141,000 after purchasing an additional 7,899 shares during the last quarter. Finally, Quadrature Capital Ltd bought a new position in Cognyte Software in the 4th quarter valued at approximately $144,000. Institutional investors own 72.92% of the company's stock.
Cognyte Software Stock Performance
Shares of Cognyte Software stock traded up $0.04 on Friday, reaching $6.90. 206,403 shares of the stock were exchanged, compared to its average volume of 444,714. The firm's 50 day moving average is $7.45 and its 200-day moving average is $6.28. Cognyte Software has a one year low of $4.00 and a one year high of $8.53. The firm has a market cap of $490.04 million, a PE ratio of -30.00 and a beta of 1.68.
Analyst Upgrades and Downgrades
A number of analysts have issued reports on CGNT shares. Wedbush boosted their price objective on shares of Cognyte Software from $5.00 to $8.00 and gave the company a "neutral" rating in a report on Thursday, April 11th. Needham & Company LLC reissued a "hold" rating on shares of Cognyte Software in a report on Tuesday, April 9th. StockNews.com raised shares of Cognyte Software from a "buy" rating to a "strong-buy" rating in a report on Wednesday, April 10th. Finally, Evercore ISI boosted their price objective on shares of Cognyte Software from $5.00 to $7.50 and gave the company an "in-line" rating in a report on Wednesday, April 10th.
Read Our Latest Report on CGNT
About Cognyte Software
(
Get Free Report)
Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company offers network intelligence analytics, threat intelligence analytics, decision intelligence analytics, and operational intelligence analytics solutions.
Read More
Before you consider Cognyte Software, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognyte Software wasn't on the list.
While Cognyte Software currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.
Get This Free Report
